Pfizer will list its COVID-19 treatment Paxlovid at a price of $1,390 per five-day course when it soon hits the commercial market, the drugmaker confirmed to Axios.

Why it matters: Paxlovid’s new listed price, first reported by the Wall Street Journal, will be more than twice the $529 paid by the federal government, which until now has maintained the entire U.S. supply of the key antiviral medication.

  • CaptFeather@lemm.ee
    link
    fedilink
    arrow-up
    12
    ·
    edit-2
    1 year ago

    I’m guessing you’re an antivaxxer? Everyone still recognized the bs Pfizer and Moderna did during the pandemic. The world is not black and white, bad companies can still do things that benefit society.

    • mommykink@lemmy.world
      link
      fedilink
      arrow-up
      2
      arrow-down
      10
      ·
      1 year ago

      everyone I dont like is a nazi

      Wrong. Got vaccinated within the first month of vaccines being given to the public and got boosted last week